IL2 and autoimmune hepatitis: low-dose IL-2 treatment increased the frequency of Tregs and the sensitivity of Tregs to IL-2 in patients with refractory AIH, and there was no significant change in other immune cells.147 Overall, restoring Treg frequency and function will be a feasible measure for the treatment of AIH.